• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    DocGo Appoints Lee Bienstock as Chief Executive Officer

    9/18/23 8:15:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email

    DocGo (NASDAQ:DCGO), a leading provider of last-mile mobile health services announced that its Board of Directors has appointed Lee Bienstock, who most recently served as the company's President and Chief Operating Officer, to the role of Chief Executive Officer, effective September 15, 2023.

    "Lee has done an exceptional job transforming DocGo through rapid growth since joining us in March 2022," said Stan Vashovsky, DocGo's co-founder and chairman of its Board of Directors. "I've known Lee for several years, and he's the perfect person to lead DocGo. I look forward to working with him to continue transforming how healthcare is delivered today, and for the future."

    Bienstock joined DocGo in 2022 after ten years at Google, where he most recently served as Global Head of Enterprise Partnerships for Devices and Services, in addition to holding key roles across Google Search, YouTube, and Fiber. Bienstock holds an MBA from the Wharton School of Business at the University of Pennsylvania, and a BS in Policy Analysis & Management, graduating with distinction from Cornell University.

    "At DocGo, we're well-positioned for innovation and growth, thanks to our outstanding team, clear mission, and cutting-edge healthcare solutions," said Bienstock. "As we build on a history of over 7.5 million patient interactions, I'm eager to guide the company to new accomplishments and even greater impact. I've worked closely with our large customers since I joined the company, and DocGo looks forward to continuing to deliver our services and forge even stronger relationships in the coming months."

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "should," "likely," "anticipates," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook" and similar expressions are used to identify these forward-looking statements. These statements are based on current expectations and beliefs and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements in this press release due to the risks, uncertainties and other factors described in the Company's filings with the Securities and Exchange Commission. More detailed information about factors that could affect future results is contained in our filings with the Securities and Exchange Commission. The "forward-looking statements" included in this press release are made only as of the date of this release. We do not have and do not undertake any obligation to publicly update any "forward-looking statements" to reflect subsequent events or circumstances, and we expressly disclaim any such obligation, except as required by law or regulation.

    About DocGo

    DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's proprietary, AI-powered technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230918906310/en/

    Get the next $DCGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DocGo downgraded by BTIG Research

      BTIG Research downgraded DocGo from Buy to Neutral

      5/9/25 8:41:42 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

      2/28/25 8:51:46 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on DocGo with a new price target

      BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

      8/18/23 7:24:03 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care